SUPPLEMENTARY NOTESreport contains color We investigated the role of nitric oxide (NO) in MPTP (l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced dopaminergic (DA) neuron death in this mouse model of Parkinson's Disease (PD). Our previous work demonstrated that the superoxide radical is involved in the MPTP neurotoxic process in SNpc DA neurons. SNpc DA neurons in mice overexpressing superoxide dismutase (SODl) were protected against MPTP-induced degeneration. Since the superoxide radical does not act alone, based on the oxidative stress hypothesis, in Specific Aim I, we demonstrated that neuronal NOS (nNOS) and inducible NOS (iNOS) are both players in MPTP-induced neurotoxicity to SNpc DA neurons. In Specific Aim n, we show that while nNOS has a role in MPTP toxicity to SNpc DA neurons, iNOS is the principle culprit here due to its upregulation in activated microglia. Peroxynitrite-induced alterations in protein tyrosine residues were demonstrated in striatum and ventral mibrain of MPTP-treated mice by measurement of nitrotyrosine, orthotyrosine and o,o-dityrosine in Specific Aim m. Furthermore, Specific Aim IV showed that proteins important to normal fimction in SNpc DA neurons, tyrosine hydroxylase and a-synuclein, are nitrated following MPTP exposure. We conclude that the superoxide radical and NO act in concert to mitiate and propagate DA neuronal death in the SNpc of MPTP-treated mice and in PD patients.
SUBJECT TERMSParkinson's disease, MPTP, neurotoxin, superoxide dismutase, free radicals, nitric oxide, transgenic mice, knockout mice Body 5
Key Research Accomplishments 6Reportable Outcomes 8
Conclusions 14References 18Appendices 22
Department of Defense Annual Report (2002) INTRODUCTIONParkinson's disease (PD) is a common neurodegenerative disorder that affects about 1,000,000 North Americans alone and that occurs in 50,000 newly diagnosed patients each year (1). This disease is characterized mainly by tremor, rigidity, akinesia and postural instability (2) all attributed to a dramatic loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) and of DA nerve terminals in the caudateputamen (3,4). Symptoms of PD can be alleviated vwth the use of levodopa and other dopamine agonists, however, they do not stop the progression of the disease. Many hypotheses abound as to the etiology of PD, however, it is the oxidative stress theory that seems to take precedence over the others. In previous studies (5,6), we have shown that reactive oxygen species (ROS) and reactive nitrogen species are involved in the PD neurodegenerative process. To demonstrate the involvement of these compounds in the PD neurodegenerative process, we have used l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a by-product of the chemical synthesis of a meperidine analogue with potent heroin-like effects (7). MPTP is a specific DA neurotoxin that replicates almost all of the hallmarks of PD in non-human primates and in various other mammalian species including a severe irreversible loss of DA neurons in the SNp...